The Living Brain and Alzheimer’s Disease: Research and Perspectives in Alzheimer's Disease
Editat de Bradley T. Hyman, Jean-Francois Demoneten Limba Engleză Paperback – 15 apr 2014
Din seria Research and Perspectives in Alzheimer's Disease
- 18% Preț: 924.45 lei
- 18% Preț: 1796.22 lei
- 18% Preț: 924.61 lei
- 5% Preț: 1072.62 lei
- 18% Preț: 937.73 lei
- 24% Preț: 1035.48 lei
- 18% Preț: 922.73 lei
- 18% Preț: 1191.79 lei
- 18% Preț: 1187.15 lei
- 18% Preț: 918.57 lei
- 5% Preț: 693.03 lei
- 5% Preț: 701.61 lei
- 5% Preț: 696.95 lei
- 15% Preț: 623.45 lei
- 5% Preț: 693.56 lei
- 5% Preț: 698.20 lei
- 5% Preț: 697.15 lei
- 5% Preț: 697.85 lei
- 15% Preț: 619.09 lei
- 5% Preț: 693.18 lei
- 15% Preț: 626.15 lei
- 18% Preț: 919.51 lei
- 5% Preț: 358.63 lei
- 15% Preț: 623.45 lei
- 5% Preț: 360.44 lei
- 18% Preț: 1187.32 lei
Preț: 622.94 lei
Preț vechi: 732.88 lei
-15% Nou
Puncte Express: 934
Preț estimativ în valută:
119.23€ • 125.08$ • 98.91£
119.23€ • 125.08$ • 98.91£
Carte tipărită la comandă
Livrare economică 29 ianuarie-12 februarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9783642639272
ISBN-10: 3642639275
Pagini: 200
Ilustrații: XV, 180 p. 50 illus., 33 illus. in color.
Dimensiuni: 155 x 235 x 11 mm
Greutate: 0.29 kg
Ediția:2004
Editura: Springer Berlin, Heidelberg
Colecția Springer
Seria Research and Perspectives in Alzheimer's Disease
Locul publicării:Berlin, Heidelberg, Germany
ISBN-10: 3642639275
Pagini: 200
Ilustrații: XV, 180 p. 50 illus., 33 illus. in color.
Dimensiuni: 155 x 235 x 11 mm
Greutate: 0.29 kg
Ediția:2004
Editura: Springer Berlin, Heidelberg
Colecția Springer
Seria Research and Perspectives in Alzheimer's Disease
Locul publicării:Berlin, Heidelberg, Germany
Public țintă
ResearchCuprins
Neuropathology of Alzheimer’s disease, as Seen in Fixed Tissues.- Cerebrospinal Fluid Biomarkers for the Diagnosis of Alzheimer’s Disease.- The Living Brain and Alzheimer’s Disease.- In Vivo Imaging of Alzheimer Pathology in Transgenic Mice Using Multiphoton Microscopy.- In Vivo Magnetic Resonance of Amyloid Plaques in Alzheimer’s Disease Model Mice.- Measuring Progression in Alzheimer’s Disease Using Sserial MRI: 4D MRI.- Validating MRI Measures of Disease Stage and Progression in Alzheimer’s Disease.- Dynamic Mapping of Alzheimer’s Disease.- Development of Benzothiazole Amyloid-Imaging Agents.- First PET Study with a Benzothiazol Amyloidimaging Agent (PIB) in Alzheimer’s Disease Patients and Hhealthy Volunteers.- Mild Cognitive Impairment (MCI): Predicting Conversion to Clinically Probable Alzheimer’s Disease with Fluoro-Deoxy-Glucose PET.- Positron Emission Tomography and Magnetic Resonance Imaging in the Study of Cognitively Normal Persons at Differential Genetic Risk for Alzheimer’s Dementia.
Textul de pe ultima copertă
How can we link the critical observations performed at autopsy with the events that occur over the previous twenty years of Alzheimer’s Disease? This is the problem posed to a group of our colleagues who are using state-of-the-art neural imaging methods in patients and in animal models to illuminate the natural history of the disease – in the living brain.